Product Information

ROPINIROLE HCL 1 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0461 per EA under NDC 00904637461. Its NADAC has been published 616 times since Jan 28, 2015.

FDA first approved this application on Mar 24, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROPINIROLE HCL 1 MG TABLET

ROPINIROLE
$0.0461per EA

Strength

1 mg/1

NDC

00904637461

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ROPINIROLE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090429

FDA Approved

3/24/2010

TE Code

AB

On Market Since

10/1/2014

Pharmacological Classes

Dopamine Agonists
Nonergot Dopamine Agonist

Price Statistics

The NADAC for ROPINIROLE HCL 1 MG TABLET has been published 616 times since Jan 28, 2015, and over the history we have for it it has declined 57.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0461 per EA
All-time high$0.1093 (Feb 11, 2015)
All-time low$0.0398 (Nov 20, 2024)
52-week high$0.0549
52-week low$0.0461
Median price$0.0573
Average price$0.0633
Largest weekly change-25.6% (Nov 20, 2024)
Weeks tracked616
Tracking sinceJan 28, 2015

Price History

1W

0.0%

1M

-3.4%

3M

-5.6%

6M

-12.6%

1Y

-12.6%

3Y

-16.2%

5Y

-13.9%

All

-57.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ROPINIROLE HCL 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 1 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0461 per EA (NDC 00904637461), effective Nov 11, 2026.

How has the price of ROPINIROLE HCL 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for ROPINIROLE HCL 1 MG TABLET has declined 57.8%. It has been tracked across 616 weekly CMS publications since Jan 28, 2015.

What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 1 MG TABLET?

Since Jan 28, 2015, the NADAC for ROPINIROLE HCL 1 MG TABLET has ranged from a low of $0.0398 (Nov 20, 2024) to a high of $0.1093 (Feb 11, 2015), with a median of $0.0573 per EA.

Are there cheaper alternatives to ROPINIROLE HCL 1 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ROPINIROLE HCL 1 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ROPINIROLE HCL 1 MG TABLET?

ROPINIROLE HCL 1 MG TABLET (NDC 00904637461) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.